Schering-Plough to Initiate Two Phase III Hepatitis Studies

redorbit.com     May 22, 2008            

Posted on: Thursday, 22 May 2008, 09:01 CDT Schering-Plough has announced that it is initiating two large Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, in patients chronically infected with hepatitis C virus genotype 1. One study will be in previously... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies